1. Home
  2. SAVA vs TAYD Comparison

SAVA vs TAYD Comparison

Compare SAVA & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • TAYD
  • Stock Information
  • Founded
  • SAVA 1998
  • TAYD 1955
  • Country
  • SAVA United States
  • TAYD United States
  • Employees
  • SAVA N/A
  • TAYD N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • TAYD Industrial Machinery/Components
  • Sector
  • SAVA Health Care
  • TAYD Industrials
  • Exchange
  • SAVA Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • SAVA 157.5M
  • TAYD 132.1M
  • IPO Year
  • SAVA N/A
  • TAYD N/A
  • Fundamental
  • Price
  • SAVA $2.82
  • TAYD $46.98
  • Analyst Decision
  • SAVA Buy
  • TAYD
  • Analyst Count
  • SAVA 2
  • TAYD 0
  • Target Price
  • SAVA $5.00
  • TAYD N/A
  • AVG Volume (30 Days)
  • SAVA 1.2M
  • TAYD 6.2K
  • Earning Date
  • SAVA 11-12-2025
  • TAYD 01-02-2026
  • Dividend Yield
  • SAVA N/A
  • TAYD N/A
  • EPS Growth
  • SAVA N/A
  • TAYD N/A
  • EPS
  • SAVA N/A
  • TAYD 2.72
  • Revenue
  • SAVA N/A
  • TAYD $44,593,219.00
  • Revenue This Year
  • SAVA N/A
  • TAYD $10.81
  • Revenue Next Year
  • SAVA N/A
  • TAYD $8.37
  • P/E Ratio
  • SAVA N/A
  • TAYD $17.28
  • Revenue Growth
  • SAVA N/A
  • TAYD N/A
  • 52 Week Low
  • SAVA $1.15
  • TAYD $29.50
  • 52 Week High
  • SAVA $33.98
  • TAYD $53.73
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 38.79
  • TAYD 49.12
  • Support Level
  • SAVA $2.65
  • TAYD $43.18
  • Resistance Level
  • SAVA $3.30
  • TAYD $50.51
  • Average True Range (ATR)
  • SAVA 0.21
  • TAYD 1.84
  • MACD
  • SAVA -0.07
  • TAYD -0.10
  • Stochastic Oscillator
  • SAVA 18.02
  • TAYD 22.37

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: